Lunit Inc. (328130.KQ)

KRW 71500.0

(-4.92%)

Market Cap (In KRW)

2064.43 Billion

Revenue (In KRW)

25.08 Billion

Net Income (In KRW)

-36.79 Billion

Avg. Volume

516.66 Thousand

Currency
KRW
Country
Open
-
Prev. Close
-
Day Range
-
Year Range
31000.0-87900.0
PE
-
EPS
-
Beta Value
1.82
ISIN
KR7328130000
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Industry
CEO
Mr. Beomseok Brandon Suh
Employee Count
-
Website
https://www.lunit.io
Ipo Date
2022-07-21
Details
Lunit Inc. develops and provides AI based software solutions for cancer screening/diagnosis and treatment. It offers AI solution for chest X-ray and mammography, as well as AI-powered biomarker for immune phenotyping and PD-L1 quantification for immunotherapy. The company was incorporated in 2013 and is based in Seoul, South Korea.